Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
2
×
europe blog main
europe top stories
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
novartis
san francisco blog main
san francisco top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
avapritinib
bioeurope
biogen
biomarin pharmaceutical
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
capmatinib
cara therapeutics
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
eli lilly
esperion
fda
What
fda
2
×
medicines
2
×
activity
address
approval
approvals
approves
bio
biogen
blueprint
cancer
carries
certain
clamped
covid
delays
designed
developing
drug
economic
fast
genetic
including
ipo
isn’t
latest
lot
new
oric’s
pass
ret
roundup
showing
signature
signatures
spread
targeted
targeting
testing
therapy
Language
unset
Current search:
medicines
×
cancer
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
